Darryl J. Sleep

A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone‐refractory prostate cancer

Michael A. Carducci, Fred Saad, Per‐Anders Abrahamsson et al. · Cancer · 2007 · 292 citations

Phase 3, randomized, controlled trial of atrasentan in patients with nonmetastatic, hormone‐refractory prostate cancer

Joel B. Nelson, William T. Love, Joseph L. Chin et al. · Cancer · 2008 · 245 citations · Full text

Efficacy and safety of ABT-335 (fenofibric acid) in combination with rosuvastatin in patients with mixed dyslipidemia: A phase 3 study

Peter H. Jones, Michael H. Davidson, Moti L. Kashyap et al. · Atherosclerosis · 2008 · 90 citations

Lipid Disorder, Cardiovascular Disease, Mixed Dyslipidemia +8

Mapping FACT-P and EORTC QLQ-C30 to Patient Health Status Measured by EQ-5D in Metastatic Hormone-Refractory Prostate Cancer Patients

Eric Q. Wu, Parvez Mulani, Max H. Farrell et al. · Value in Health · 2007 · 83 citations · Full text

Urology, Genitourinary Cancer, Medicine +5

COMBINATION OF SYMPTOM SCORE, FLOW RATE AND PROSTATE VOLUME FOR PREDICTING BLADDER OUTFLOW OBSTRUCTION IN MEN WITH LOWER URINARY TRACT SYMPTOMS

Graeme S. Steele, Darryl J. Sleep, Subbarao V. Yalla · The Journal of Urology · 2000 · 82 citations